AmpleLogic aPaaS for Life Science vs. GeneXus

Develop a large and complex product, integrated with multiple tourism service providers, reservation systems, and e-commerce sites, with constant needs to adapt to changes and innovation in business and technology, with a small development team that must have a lot of business knowledge

• It allows to focus on the solution instead of seeing technical or implementation limitations as it is multiplatform.
• Development times are shorter due to its easy implementation and on the same platform manage the database, services and front.
• Being multiplatform allows us to implement the solution in different technologies.

• Some errors at building time that are difficult to figure out. In the deployment and executions, sometimes you get errors not easy to figure out.
• Now it's fast, but when you create a large solution, it slows down.

Usability of the tool by a developer who is well trained in the use of GeneXus and with good judgment is excellent. It allows them to know good practices in the generation of code for the database as well as for the backend and the frontend. It allows us to achieve better standardization within the development team and to present solutions and solve complex problems in a very simple way.

Sometimes the support takes a little while, but in the end they always have good answers and the people who answer you are very prepared even for questions outside of GeneXus.

Incentivized

GeneXus has a wider approach in terms of the platform it supports. It has been in the market evolving with technology changes for more than 30 years. It has a better business model for the users, instead of charging for the amount of developments we make or the amount of users we have, it only charges per developer station.

• Being able to work with a multidisciplinary but small team of professionals with a lot of focus on the needs of the business
• GeneXus to take care especially the permanent evolution of the technology